See the DrugPatentWatch profile for wegovy
Common Gastrointestinal Side Effects of Wegovy
Wegovy (semaglutide) most often causes nausea, diarrhea, vomiting, constipation, and abdominal pain. These affect more than 1 in 10 users, with nausea being the most frequent—reported in up to 44% of patients in clinical trials.[1][2]
How Often Do They Occur and How Long Do They Last?
Nausea peaks in the first 4-8 weeks as patients ramp up the dose from 0.25 mg to 2.4 mg weekly, then often lessens. Diarrhea hits 30% early on, constipation about 24%, vomiting 24%, and stomach pain 20%. Most resolve within weeks, but 5-10% may persist or lead to discontinuation.[1][3]
Why Does Wegovy Cause These?
As a GLP-1 receptor agonist, it slows stomach emptying, reduces appetite, and alters gut motility, triggering these effects. Higher doses increase risk.[2]
Severe or Less Common GI Issues
Rare but serious problems include gastroparesis (stomach paralysis), bowel obstruction, or pancreatitis—seen in under 1% but requiring medical attention. Symptoms like severe pain, persistent vomiting, or bloody stools signal urgency.[1][4]
Tips Patients Use to Manage Them
Start low and go slow on dosing. Eat smaller meals, avoid fatty/greasy foods, stay hydrated, and try ginger or over-the-counter anti-nausea aids. Doctors may pause dose increases if issues arise.[3][5]
Compared to Ozempic or Mounjaro
Wegovy and Ozempic (same drug, different doses) share identical GI profile. Mounjaro (tirzepatide) has similar rates but slightly higher diarrhea/vomiting in head-to-head data.[2][6]
[1]: FDA Wegovy Label
[2]: Novo Nordisk Prescribing Info
[3]: NEJM STEP Trials
[4]: Drugs.com Side Effects
[5]: Mayo Clinic Management
[6]: SURMOUNT Trials Comparison